Mroueh Mohammad, Daher Costantine, Hariri Essa, Demirdjian Sally, Isber Samih, Choi Eun Sang, Mirtamizdoust Babak, Hammud Hassan H
School of Pharmacy, Lebanese American University, Byblos, Lebanon.
School of Arts and Sciences, Lebanese American University, Byblos, Lebanon.
Chem Biol Interact. 2015 Apr 25;231:53-60. doi: 10.1016/j.cbi.2015.02.023. Epub 2015 Mar 7.
The dinuclear complex bis[(μ(2)-chloro)chloro(1,10-phenanthroline)copper(II)] (1) was synthesized, and characterized by X-ray, FTIR and thermal analysis. The fitting of magnetic susceptibility and magnetization curve of (1) indicates the occurrence of weak antiferromagnetic exchange interaction between copper(II) ions. The electronic structure has been also determined by density functional theory (DFT) method. Complex (1) displayed potent anticancer activity against B16 (Melanoma), MDA-MB-32 (Breast Adenocarcinoma), A549 (Lung Adenocarcinoma), HT-29 (Colon Adenocarcinoma) and SF (Astrocytoma) cell lines with an average IC50 value of 0.726 μg/ml compared to 4.88 μg/ml for cisplatin. Complex (1) has a better therapeutic index and toxicological profile than cisplatin, and has demonstrated a potential chemotherapeutic property.
合成了双核配合物双[(μ(2)-氯)氯(1,10-菲咯啉)铜(II)] (1),并通过X射线、傅里叶变换红外光谱和热分析对其进行了表征。(1)的磁化率和磁化曲线拟合表明铜(II)离子之间存在弱反铁磁交换相互作用。其电子结构也通过密度泛函理论(DFT)方法确定。配合物(1)对B16(黑色素瘤)、MDA-MB-32(乳腺腺癌)、A549(肺腺癌)、HT-29(结肠腺癌)和SF(星形细胞瘤)细胞系显示出较强的抗癌活性,平均IC50值为0.726 μg/ml,而顺铂为4.88 μg/ml。配合物(1)比顺铂具有更好的治疗指数和毒理学特性,并已显示出潜在的化疗性能。